INTRODUCTION
Osteoclasts (OCs), macrophages (MFs), and dendritic cells (DCs) are closely related cells of the myeloid lineage (Arai et al., 1999) . Terminally differentiated OCs fuse to form large, multinucleated cells that resorb bone. OCs differentiate from precursors under influence of RANK ligand (L) that is produced by bone-forming osteoblasts. Ordinarily, OCs and osteoblasts thus maintain bone homeostasis in a balanced interaction (Theill et al., 2002) . However, in cancer and autoimmune and inflammatory diseases, OC formation can be promoted by RANKL-expressing tumor or immune cells, which facilitates bone metastasis, pathological bone loss, and remodeling (Walsh et al., 2006) . Although OCs are of key importance, their developmental pathway is largely unknown as testified by the striking absence of OCs in most depictions of the hematopoietic tree.
The hematopoietic tree describes the developmental pathways of all blood cells emanating from the pluripotent hematopoietic stem cell (HSC). The self-renewing HSC yields the multipotent progenitor (MPP), which in turn gives rise to more lineage-restricted, oligopotent precursors. The classical model dictates that the MPP bifurcates into a common myeloid progenitor (CMP) and a common lymphoid progenitor (CLP). The CMP in turn would bifurcate into the megakaryocyte/erythrocyte progenitor (MEP) and the granulocyte (GR)/MF progenitor (GMP). GRs, monocytes/MFs, and DCs were thought to arise downstream of the GMP (Weissman and Shizuru, 2008) . However, in an alternative model based on mouse data, the MPP bifurcates into a precursor with megakaryocyte/ erythroid potential and one with combined myeloid and lymphoid potential (Kawamoto et al., 2010) . This myeloid-based model was supported by the identification of a murine lympho/myeloid precursor (LMPP) devoid of megakaryocyte/erythroid potential (Adolfsson et al., 2005) . Also in line with the myeloid-based model was the identification of a human multilymphoid progenitor (MLP) that gave rise to lymphoid cells, MFs, and DCs (Doulatov et al., 2010) . This MLP replaced the CLP in the scheme of human hematopoiesis (Doulatov et al., 2012) . In the proposed scenario, both MLP and GMP can yield MFs and DCs, whereas the GMP can additionally give rise to GRs ( Figure 1A ). Findings in humans also supported the existence of the LMPP (Goardon et al., 2011) and suggested that it bifurcates into the MLP and the GMP (Görgens et al., 2013; Figure 1A) . Recent data in human also revise the view on the CMP, in accordance to findings in the mouse (Kawamoto et al., 2010) : the human MPP was found to yield a common erythro-myeloid progenitor (EMP) that gives rise to the MEP and to a precursor of eosinophilic and basophilic GRs (EoBP) (Mori et al., 2009; Görgens et al., 2013) . In the revised scheme, the CMP is absent and the GMP lies downstream of the LMPP ( Figure 1A ).
The human GMP was found to yield only neutrophils and not other types of GRs (Görgens et al., 2013) . Exactly how monocytes/MFs and DCs develop downstream of the GMP is intensely studied both in human and mouse. In the mouse, a common monocyte/MF/DC progenitor (MDP) has been proposed. The MDP is thought to give rise to a common DC progenitor (CDP) that exclusively forms plasmacytoid and conventional DCs and to a common monocyte progenitor (cMoP) that exclusively forms monocytes and MFs (Liu and Nussenzweig, 2010; Hettinger et al., 2013) . In contrast, little attention is paid to OC development. Seminal studies in the mouse have demonstrated that OCs, MFs, and DCs derive from a common MF/OC/DC progenitor (MODP) that lies downstream of the GMP (Arai et al., 1999; Miyamoto et al., 2001) , as confirmed by others (Jacome-Galarza et al., 2013) . However, equivalent findings on the origin of the OC in human hematopoiesis have thus far not been reported.
We previously examined the fate of OC precursors in mouse BM. Herein, we confirmed and refined the earlier definition of the MODP and found a downstream MOP (Xiao et al., 2013) . Using the methodology and cues from this mouse study, we searched for the MODP in humans and report it here.
RESULTS AND DISCUSSION

OC Precursors Are Enriched in the CD11b
Human BM To identify human OC precursors, we flow cytometrically purified bone marrow (BM) populations from healthy pediatric donors (Table S1 ) and analyzed their differentiation potential in vitro. As markers, we used presence of CD34 as progenitor marker and, by analogy with the mouse MODP, presence of c-KIT (CD117) and absence of CD11b (Arai et al., 1999; Xiao et al., 2013) . We also examined FLT3 (CD135) as potential marker, because it is on the mouse MODP ( Figure S1A ). The tyrosine kinase receptor FLT3 is essential for homeostatic DC development (McKenna et al., 2000) . It is expressed on the CDP and on upstream precursors in the mouse (Liu and Nussenzweig, 2010; Weissman and Shizuru, 2008) , where high FLT3 levels distinguish the mouse LMPP from the MEP (Adolfsson et al., 2005) . Among CD11b À BM cells, we identified CD34 Figure S1B ). Mature OCs were identified by positive staining for tartrate-resistant acid phosphatase (TRAP) and vitronectin receptor ( Figure S1C ) and by a multi-nuclear appearance ( Figure 1C ). To narrow down the OC precursor population, we tested as additional markers c-FMS (alias CSF1R/CD115); the M-CSF receptor for that is present on the MODP (Arai et al., 1999) and on designated DC and MF precursors in the mouse (Liu and Nussenzweig, 2010; Hettinger et al., 2013) . CSF1R mRNA was present in CD34 + c-KIT + FLT3
+ precursor cells ( Figure 1D ), but we could not detect the protein at the cell surface (results not shown). We also tested CD27 that marks the murine MODP (Xiao et al., 2013; Figure S1A) , but it was not synthesized in CD11b À CD34 + c-KIT + FLT3 + BM cells ( Figure 1D ). We next considered IL3Ra (CD123), because its mRNA was enriched in the FLT3 + fraction of CD11b Figure 1D ) and it discriminates CMP and GMP from MEP (Mori et al., 2009 Figure 1E ). These populations corresponded to $1.7% and $0.5%, respectively, of live, ficolled BM cells ( Figure 1F ). Both precursor populations were negative for a lineage (Lin) marker set composed of CD2, CD3, CD14, CD16, CD19, CD56, and CD235a ( Figure 1E ). They also lacked CD7 and CD10 ( Figure 1D ; results not shown) that are acquired at the level of the MLP. They expressed CD38 (Figure 1G) that is acquired downstream of the MPP (Doulatov et al., 2010 (Manz et al., 2002) . CD45RA is also expressed on the MLP, but not further upstream (Doulatov et al., 2010 Figure 2D ).
We next examined MF-differentiation potential. The IL3Ra high subset was more efficient at MF formation than the IL3Ra low subset . When plated at 1,000 cells per well, the IL3Ra high subset generated 7,000-10,000 cells over 14 days ( Figure 2F ), most of which were MFs as indicated by a CD14 + CD68 + phenotype ( Figure 2G ). Figure S2A ). XCR1-and Clec9a-expressing cells were clearly enriched in the DC culture as compared to the MF culture ( Figure 3A ). This agrees with Balan et al. (2014) , who identified XCR1 and Clec9a, but not CD141, as markers that discriminate between progenitor-derived DCs and monocyte-derived DCs. The DC culture contained more XCR1 + Clec9a + cells than the MF culture ( Figure 3B ), and these cells were enriched for the DC markers FLT3 and CD1c. In the MF culture, XCR1 + Clec9a + cells were enriched for the MF marker CD14 high ( Figure 3B ). The XCR1 À Clec9a À cells in the DC culture also differed from those in the MF culture (Figure 3C ). In the DC culture, a large proportion of XCR1 À Clec9a À expressed the DC markers FLT3 and/or CD1c, but this was not the case in the MF culture. Moreover, in the MF culture, the XCR1 À Clec9a À cells were uniformly CD14 high , but this was not the case in the DC culture. Furthermore, the discriminatory monocyte/MF marker FCGR2A (Balan et al., 2014) was enriched in the MF cultures as compared to the DC cultures ( Figure S2B ), and cells from the MF cultures had a much greater ability to phagocytose beads than cells from the DC cultures (Figure S2C) . Thus, the IL3a high subset gives rise to distinct progenies under DC-versus MF-differentiation conditions, arguing that it is a common progenitor for DCs and MFs. Oligopotency of the progenitors was tested in clonogenic assays. From the IL3Ra low subset, but not from the IL3Ra high subset, single cells could be expanded with cytokines on a mesenchymal stem cell layer ( Figure 3D ). Figure 4A ). This confirmed the discriminatory potential of the IL3Ra marker. At p < 0.001, 649 protein-coding genes were differentially expressed between the two subsets, indicating their close relationship but distinct nature. Among these, 97 genes with the highest level of differential expression were used to make a heatmap that specifies the distinct nature of the two subsets ( Figure 4B ). Furthermore, the 649 differentially expressed protein-coding genes were analyzed by ingenuity pathway analysis (IPA). Gene clusters upregulated in the IL3Ra high subset included the functional categories ''differentiation of MFs,'' ''differentiation of OCs,'' and ''differentiation of antigen-presenting cells'' ( Figure 4C ), indicating a further commitment to MF/OC/DC differentiation in the transition from the IL3Ra low to the IL3Ra high phenotype. Gene clusters downregulated in the IL3Ra high subset included the functional categories ''differentiation of B lymphocytes,'' ''quantity of granulocytes,'' and ''quantity of eosinophils,'' consistent with differentiation away from the GR fate (Figure 4C) . In addition, a gene cluster denoting ''differentiation of cells'' was upregulated and a gene cluster denoting ''proliferation of hematopoietic progenitor cells'' was downregulated, in accordance with further commitment to a differentiated cell fate ( Figure 4C ). The IL3Ra high subset showed higher mRNA expression of transcription factors important for pDC, cDC, and MF development, including SPIB, IRF4, IRF8, SPI1/PU.1, and ID2 (Figures 4C and 4D ; Belz and Nutt, 2012; Lawrence and Natoli, 2011; Rosenbauer and Tenen, 2007) . This indicated that both pDC and cDC developmental capacity is contained within the human MODP. Furthermore, in the IL3Ra high subset, CSF1R was upregulated ( Figure 4D ), as well as OSCAR, TYROBP (DAP12), and SYK ( Figure 4C ), a membrane receptor and signaling molecules that drive OC differentiation (Takayanagi, 2007) . Both IL3-Ra high and IL3Ra low precursor populations expressed myeloperoxidase (MPO) that is diagnostic for the GMP (Manz et al., 2002) at similarly high levels ( Figure 4D ). Collectively, these deep-sequencing data strongly support, in an unbiased fashion, our phenotypic and functional definitions of the human GMODP and MODP. Whereas this paper was in the final stage of revision, Lee et al. (2015) populations should be tested for OC potential. Also, the CDP population should be tested for MF-differentiation potential with M-CSF, because only GM-CSF was used. Nevertheless, we fully agree that an M(O)DP exists downstream of the GM(O)DP. Lee et al. (2015) proved both pDC and cDC potential of their precursors by deep sequencing of culture-derived and primary cells, supporting the common DC potential revealed by deep sequencing in our MODP. Future work should address the functionality of the culture-derived cells. Also, additional markers must be found to discern the MODP and proposed CDP. Understanding the development of OC, DC, and MF is important for clinical diagnostics, targeted drug-based therapy, and cellular therapy. Identification of the MODP will also facilitate generation of these cell types, with precursor stemness benefitting expansion and cell yield.
EXPERIMENTAL PROCEDURES
Human BM and Flow Cytometry BM was obtained from healthy children that were donors for their sibling, with approval of the medical ethical committee of Leiden University Medical School (protocol P08.001) and with parental informed consent. BM mono-nuclear cells were isolated by density gradient centrifugation on Ficoll and cryopreserved until use. Cells were stained with antibodies in medium with 2% FCS. Prior to sorting, 0.01% deoxyribonuclease I was added to prevent cell clumping and 1 mg/ml propidium iodide (Sigma-Aldrich) to exclude dead cells. Cells were sorted on a FACSAria and analyzed on an LSRFortessa (BD Biosciences) or CyAn (Beckman Coulter Genomics). Data were analyzed with FloJo software. For mAbs used for flow cytometry, see Table S2 .
In Vitro Differentiation Cultures
In in vitro differentiation cultures, 1,000 sorted precursor cells were cultured per well in 96-well plates (BD Falcon). Culture conditions were as follows: (1) OC differentiation: 7-9 days in 200 ml of MEM-a with 10% FCS, 25 ng/ml recombinant human (rh) M-CSF, and 40 ng/ml rh RANKL. (2) DC differentiation: 8 or 14 days in IMDM with 10% FCS, 25 ng/ml rh M-CSF, and 200 ng/ml rh FLT3L (and 10 ng/ml IL-3 for the experiment depicted in Figures 3A-3C ). For MF-, GR-, and B-cell differentiation, cells were cultured on a monolayer of OP9 cells. (3) MF differentiation: 8 or 14 days in IMDM with 10% FCS, 25 ng/ml rh M-CSF, and 1,000 U/ml rh IL-6 (Chomarat et al., 2000) . (4) GR differentiation: 14 days in IMDM with 10% FCS and 100 ng/ml rh G-CSF (Choi et al., 2009) . (5) B-cell differentiation: 3 to 4 weeks in RPMI-1640 with 10% FCS and 15 ng/ml rh IL-7 (Miltenyi Biotech; Vieira and Cumano, 2004) . For clonogenic assays, cells were sorted at one cell per well and either pre-expanded in IMDM with 10% FCS and 5 ng/ml SCF, 10 ng/ml TPO, 5 ng/ml M-CSF, and 20 ng/ml Flt3L on a mesenchymal stem cell layer (Xiao et al., 2013) or cultured directly. Growth factors were from R&D Systems unless otherwise indicated. For analysis of cell differentiation, see Supplemental Information.
RNA Deep Sequencing and PCR
For mRNA deep sequencing, 10,000-40,000 precursors were flow cytometrically sorted, dissolved in Trizol reagent (Ambion), and delivered to the NKI Genomics Core Facility. Here, mRNA was isolated and deep sequencing was performed using a HiSeq200 (Illumina). Sequence reads were aligned with TopHat software to the Ensembl gene set Homo sapiens GRCh37.66. Reads were counted using htseq-count software. Hierarchical clustering was done in R and uses 1-correlation as the distance function. Reads for protein-coding genes were normalized and analyzed for differential expression using R package limma. The heatmap was generated using Qlucore Omics Explorer software (Qlucore). For real-time (RT) and/or quantitative (q) PCR, RNA was isolated using the RNeasy Mini Kit (QIAGEN) and treated with DNase I (QIAGEN) to remove genomic DNA. Next, cDNA was prepared on a Peltier Thermal Cycler (BioRad), using SuperScript II reverse transcriptase (Invitrogen), and either RT-PCR or qPCR was performed with the primers listed in Table S3 . See Supplemental Information for further details.
Statistical Analysis
See Supplemental Information.
ACCESSION NUMBERS
The GEO accession number for the data reported in this paper is GSE65996. Table S1 . Donor information.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Analysis of OC differentiation -After culture, the presence of OC was assessed with the TRAP staining kit (Sigma Aldrich), according to manufacturer's instructions. For this purpose, the culture medium was carefully removed and the cells were washed with 100 µl of pre-warmed (37°C) PBS to remove non-adherent cells.
Next, cells were fixed at room temperature in 4% v/v paraformaldehyde. Fixed cells were washed with PBS, followed by MilliQ (Millipore) and stained for TRAP by incubation with TRAP staining solution for 5-10 min.
After washing, cells were stained with 5% v/v 4',6-Diamidino-2-Phenylindole (DAPI) staining solution, to allow visualization of their nuclei. Next, semi-high-throughput microscopy was performed with a fully CD68 was detected by intracellular staining, wherein cells were fixed and permeabilized (reagents from eBioscience) after live cell surface staining for other markers. Phagocytosis ability was tested by adding SPHERO TM particles (3.0-3.4 µm) to cells from the MΦ-and DC cultures at 10:1 (beads:cell) ratio. Particle uptake was analysed after 16 hours of incubation under culture conditions by cell fixation, followed by fluorescence and phase contrast microscopy (Nikon Eclipse TS100) and image processing by Image J.
PCR -For RT-PCR, cDNA was amplified with DNA Taq Polymerase (Invitrogen) on a Pelter Thermal Cycler and run on a 1.5% agarose gel (Agarose MP, Roche). For QPCR, cDNA was amplified on a StepOnePlus
Real-Time PCR System (Applied Biosystems) using Fast SYBR Green Master Mix (Applied Biosystems).
